Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study

Introduction: Solid Organ Transplants (SOT) is at increased risk of Coronavirus Disease 2019 (COVID-19) infection, which may result in acute graft dysfunction and even death. While the disease has been well studied in the general population, it is not the case in renal transplant recipients. The poo...

Full description

Bibliographic Details
Main Authors: Shiva Kumar Ammayappan, Arul Rajagopalan, Jegan Arunachalam, Arun Prasath, Rakesh Durai, Manorajan Rajendran, Benoy Varghese, Shanmuganathan Velu
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/16340/52091_CE[Ra1]_F(KR)_PF1(RD_SHU_SS)_PFA(RD_KM)_PN(KM).pdf
_version_ 1811166306869706752
author Shiva Kumar Ammayappan
Arul Rajagopalan
Jegan Arunachalam
Arun Prasath
Rakesh Durai
Manorajan Rajendran
Benoy Varghese
Shanmuganathan Velu
author_facet Shiva Kumar Ammayappan
Arul Rajagopalan
Jegan Arunachalam
Arun Prasath
Rakesh Durai
Manorajan Rajendran
Benoy Varghese
Shanmuganathan Velu
author_sort Shiva Kumar Ammayappan
collection DOAJ
description Introduction: Solid Organ Transplants (SOT) is at increased risk of Coronavirus Disease 2019 (COVID-19) infection, which may result in acute graft dysfunction and even death. While the disease has been well studied in the general population, it is not the case in renal transplant recipients. The poor immunological response of the vaccine in post renal transplant patients, the emergence of newer strains, and the possibility of a third wave in India, makes it even more important to know more about the course and outcome of the disease in post renal transplant patients. Aim: To evaluate the demographics, clinical presentation, biochemical profile, course of hospitalisation in post kidney transplant patients with COVID-19. Materials and Methods: This retrospective observational study study with 18 patients was conducted in Madurai Medical College, Tamil Nadu, India for duration of four months, from May 2021 to August 2021 and data collection from May 2021 to July 2021 and data analysis in August 2021. All post kidney transplant patients having evidence of COVID-19 were included. Detailed clinical history, biochemical profile, radiological findings, treatment, and final outcomes were collected and compared. Non parametric statistical tests were used, in addition to Chi-square test and odds ratio. Kaplan-Meier plot was used for survival analysis. Results: The most common presentation was fever 15 (83.3%), followed by cough 10 (55.6%). C-reactive Protein (CRP) {65 mg/L (11.48-94.48)}, D-dimer {0.72 mcg/mL (0.59-1.1)}, serum creatinine {3.5 mg/dL (2.12-5.93)}, and platelet count {200,000 cells/cu.mm (1.75-2.22)} and showed statistically significant (p<0.05) association with the outcome. About 15 (83.3%) patients developed Acute Kidney Injury (AKI). Seven patients (38.9%) had stage three AKI necessitating haemodialysis, of which six did not survive. The median survival time was 22 days, with 95% confidence interval (19.792-24.208), with case fatality rate of 33.3% Conclusion: Post kidney transplant patients are at high risk of contracting COVID-19. CRP, D-dimer, serum creatinine, platelet counts, and arterial oxygen saturation may serve as prognostic markers. Dialysis may be required in view of high incidence of AKI and acute graft dysfunction, though the outcome seems dismal in such patients. Hence, the need for early hospitalisation and more effective treatment protocol is essential to improve outcome.
first_indexed 2024-04-10T15:50:15Z
format Article
id doaj.art-067e5acb5c2f4b18acd5162a1a5d8183
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T15:50:15Z
publishDate 2022-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-067e5acb5c2f4b18acd5162a1a5d81832023-02-11T10:21:38ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-05-01165OC17OC2310.7860/JCDR/2022/52091.16340Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational StudyShiva Kumar Ammayappan0Arul Rajagopalan1Jegan Arunachalam2Arun Prasath3Rakesh Durai4Manorajan Rajendran5Benoy Varghese6Shanmuganathan Velu7Resident, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Associate Professor, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Assistant Professor, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Assistant Professor, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Assistant Professor, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Professor, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Resident, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Resident, Department of Nephrology, Madurai Medical College, Madurai, Tamil Nadu, India.Introduction: Solid Organ Transplants (SOT) is at increased risk of Coronavirus Disease 2019 (COVID-19) infection, which may result in acute graft dysfunction and even death. While the disease has been well studied in the general population, it is not the case in renal transplant recipients. The poor immunological response of the vaccine in post renal transplant patients, the emergence of newer strains, and the possibility of a third wave in India, makes it even more important to know more about the course and outcome of the disease in post renal transplant patients. Aim: To evaluate the demographics, clinical presentation, biochemical profile, course of hospitalisation in post kidney transplant patients with COVID-19. Materials and Methods: This retrospective observational study study with 18 patients was conducted in Madurai Medical College, Tamil Nadu, India for duration of four months, from May 2021 to August 2021 and data collection from May 2021 to July 2021 and data analysis in August 2021. All post kidney transplant patients having evidence of COVID-19 were included. Detailed clinical history, biochemical profile, radiological findings, treatment, and final outcomes were collected and compared. Non parametric statistical tests were used, in addition to Chi-square test and odds ratio. Kaplan-Meier plot was used for survival analysis. Results: The most common presentation was fever 15 (83.3%), followed by cough 10 (55.6%). C-reactive Protein (CRP) {65 mg/L (11.48-94.48)}, D-dimer {0.72 mcg/mL (0.59-1.1)}, serum creatinine {3.5 mg/dL (2.12-5.93)}, and platelet count {200,000 cells/cu.mm (1.75-2.22)} and showed statistically significant (p<0.05) association with the outcome. About 15 (83.3%) patients developed Acute Kidney Injury (AKI). Seven patients (38.9%) had stage three AKI necessitating haemodialysis, of which six did not survive. The median survival time was 22 days, with 95% confidence interval (19.792-24.208), with case fatality rate of 33.3% Conclusion: Post kidney transplant patients are at high risk of contracting COVID-19. CRP, D-dimer, serum creatinine, platelet counts, and arterial oxygen saturation may serve as prognostic markers. Dialysis may be required in view of high incidence of AKI and acute graft dysfunction, though the outcome seems dismal in such patients. Hence, the need for early hospitalisation and more effective treatment protocol is essential to improve outcome.https://www.jcdr.net/articles/PDF/16340/52091_CE[Ra1]_F(KR)_PF1(RD_SHU_SS)_PFA(RD_KM)_PN(KM).pdfacute graft dysfunctionbiopsycoronavirus disease 2019dialysisimmunosuppressivesrejection
spellingShingle Shiva Kumar Ammayappan
Arul Rajagopalan
Jegan Arunachalam
Arun Prasath
Rakesh Durai
Manorajan Rajendran
Benoy Varghese
Shanmuganathan Velu
Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
Journal of Clinical and Diagnostic Research
acute graft dysfunction
biopsy
coronavirus disease 2019
dialysis
immunosuppressives
rejection
title Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
title_full Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
title_fullStr Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
title_full_unstemmed Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
title_short Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
title_sort clinical course and outcome of covid 19 in kidney transplant recipients a single centre retrospective observational study
topic acute graft dysfunction
biopsy
coronavirus disease 2019
dialysis
immunosuppressives
rejection
url https://www.jcdr.net/articles/PDF/16340/52091_CE[Ra1]_F(KR)_PF1(RD_SHU_SS)_PFA(RD_KM)_PN(KM).pdf
work_keys_str_mv AT shivakumarammayappan clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT arulrajagopalan clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT jeganarunachalam clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT arunprasath clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT rakeshdurai clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT manorajanrajendran clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT benoyvarghese clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy
AT shanmuganathanvelu clinicalcourseandoutcomeofcovid19inkidneytransplantrecipientsasinglecentreretrospectiveobservationalstudy